GKHT Medical Technology Co., Ltd. Class A

GKHT Medical Technology Co., Ltd. Class A

SSZSE:301370
7.79
CNY
-0.11
(-1.39%)
-0.02EPS
339.86P/E
4.11BMarket Cap

Total Valuation

CNY

As of September 30, 2026, GKHT Medical Technology Co., Ltd. Class A carries a market capitalization of 4.11B, placing it among publicly traded companies globally. Its enterprise value stands at 5.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.11B
Enterprise Value5.05B

Share Statistics

As of September 30, 2026, GKHT Medical Technology Co., Ltd. Class A has 470.60M shares outstanding.

Shares Outstanding470.60M

Valuation Ratios

As of September 30, 2026, GKHT Medical Technology Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 339.86. The price-to-sales ratio is 0.61, and the price-to-book ratio stands at 1.67.

PE Ratio339.86
PS Ratio0.61
PB Ratio1.67
P/TBV Ratio1.79

Enterprise Valuation

As of September 30, 2026, GKHT Medical Technology Co., Ltd. Class A trades at an EV/EBITDA multiple of 235.47 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.78 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 235.47 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 5.05B versus a market cap of 4.11B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.78
EV / EBITDA235.47
EV / EBIT235.47

Financial Position

As of September 30, 2026, GKHT Medical Technology Co., Ltd. Class A maintains a current ratio of 1.48, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 60.91, indicating elevated leverage, while an interest coverage ratio of 0.72 demonstrates limited ability to service its debt obligations.

Current Ratio1.48
Quick Ratio0.16
Debt / Equity60.91
Debt / EBITDA70.08
Interest Coverage0.72

Financial Efficiency

CNY

These figures cover the twelve months ended September 30, 2026. The company generates approximately 7.39M in revenue per employee across its workforce of 873.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee7.39M
Employee Count873.00

Taxes

CNY

Over the twelve months ended September 30, 2026, GKHT Medical Technology Co., Ltd. Class A recorded 33.54M in income tax expense. That works out to an effective tax rate of 132.56, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 25.30M, leaving 11.67M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax33.54M
Effective Tax Rate132.56

Stock Price Statistics

CNY

As of the close on November 17, 2026, GKHT Medical Technology Co., Ltd. Class A's stock has declined approximately 35.78% over the past 52 weeks. The 50-day moving average sits at 8.41, while the 200-day moving average is 9.53.

52-Week Price Change-35.78%
50-Day Moving Average8.41
200-Day Moving Average9.53

Income Statement

CNY

Over the twelve months ended September 30, 2026, GKHT Medical Technology Co., Ltd. Class A generated 6.45B in revenue and converted that into 11.67M in net income, yielding earnings per share of -0.02. EBITDA reached 21.43M, while operating income came in at 156.58M.

Revenue6.45B
Gross Profit654.73M
Operating Income156.58M
Pretax Income25.30M
Net Income11.67M
EBITDA21.43M
EBIT21.43M
Earnings Per Share (EPS)-0.02

Balance Sheet

CNY

As of September 30, 2026, GKHT Medical Technology Co., Ltd. Class A holds 573.40M in cash and equivalents against 1.50B in total debt, resulting in a net debt position of 814.91M. Total book value stands at 2.46B, with working capital of 1.73B providing operational flexibility.

Cash & Cash Equivalents573.40M
Total Debt1.50B
Net Debt814.91M
Equity (Book Value)2.46B
Book Value Per Share5.23
Working Capital1.73B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-154.71M

Margins

Over the twelve months ended September 30, 2026, GKHT Medical Technology Co., Ltd. Class A posted a gross margin of 10.15, reflecting its pricing power and cost economics. The operating margin of 2.43 and net profit margin of 0.18 provide insight into operational efficiency.

Gross Margin10.15
Operating Margin2.43
Pretax Margin0.39
Profit Margin0.18
EBITDA Margin0.33

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, GKHT Medical Technology Co., Ltd. Class A paid dividends of 0.26 per share. The dividend payout ratio of -419.86 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 15.03, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to GKHT Medical Technology Co., Ltd. Class A shareholders.

Dividend Per Share0.26
Payout Ratio-419.86
Shareholder Yield15.03

Scores

As of September 30, 2026, GKHT Medical Technology Co., Ltd. Class A has an Altman Z-Score of 2.34, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.34